Nondisclosure of HIV status in a clinical trial setting: Antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection

Mark A. Marzinke; William Clarke; Lei Wang; Vanessa Cummings; Ting Yuan Liu; Estelle Piwowar-Manning; Autumn Breaud; Sam Griffith; Susan Buchbinder; Steven Shoptaw; Carlos Del Rio; Manya Magnus; Sharon Mannheimer; Sheldon D. Fields; Kenneth H. Mayer; Darrell P. Wheeler; Beryl A. Koblin; Susan H. Eshleman; Jessica M. Fogel

doi:10.1093/cid/cit672

Nondisclosure of HIV status in a clinical trial setting: Antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection

Mark A. Marzinke, William Clarke, Lei Wang, Vanessa Cummings, Ting Yuan Liu, Estelle Piwowar-Manning, Autumn Breaud, Sam Griffith, Susan Buchbinder, Steven Shoptaw, Carlos Del Rio, Manya Magnus, Sharon Mannheimer, Sheldon D. Fields, Kenneth H. Mayer, Darrell P. Wheeler, Beryl A. Koblin, Susan H. Eshleman, Jessica M. Fogel

College of Nursing

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Abstract

In The HIV Prevention Trials Network 061 study, 155 human immunodeficiency virus (HIV)-infected men reported no prior HIV diagnosis; 83 of those men had HIV RNA levels of <1000 copies/mL at enrollment. Antiretroviral drug testing revealed that 65 of the 83 (78.3%) men were on antiretroviral treatment. Antiretroviral drug testing can help distinguish between newly diagnosed and previously diagnosed HIV infection.

Original language	English (US)
Pages (from-to)	117-120
Number of pages	4
Journal	Clinical Infectious Diseases
Volume	58
Issue number	1
DOIs	https://doi.org/10.1093/cid/cit672
State	Published - Jan 1 2014

All Science Journal Classification (ASJC) codes

Microbiology (medical)
Infectious Diseases

Access to Document

10.1093/cid/cit672

Fingerprint Dive into the research topics of 'Nondisclosure of HIV status in a clinical trial setting: Antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection'. Together they form a unique fingerprint.

Cite this

Marzinke, M. A., Clarke, W., Wang, L., Cummings, V., Liu, T. Y., Piwowar-Manning, E., Breaud, A., Griffith, S., Buchbinder, S., Shoptaw, S., Del Rio, C., Magnus, M., Mannheimer, S., Fields, S. D., Mayer, K. H., Wheeler, D. P., Koblin, B. A., Eshleman, S. H., & Fogel, J. M. (2014). Nondisclosure of HIV status in a clinical trial setting: Antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. Clinical Infectious Diseases, 58(1), 117-120. https://doi.org/10.1093/cid/cit672

Marzinke, Mark A. ; Clarke, William ; Wang, Lei ; Cummings, Vanessa ; Liu, Ting Yuan ; Piwowar-Manning, Estelle ; Breaud, Autumn ; Griffith, Sam ; Buchbinder, Susan ; Shoptaw, Steven ; Del Rio, Carlos ; Magnus, Manya ; Mannheimer, Sharon ; Fields, Sheldon D. ; Mayer, Kenneth H. ; Wheeler, Darrell P. ; Koblin, Beryl A. ; Eshleman, Susan H. ; Fogel, Jessica M. / Nondisclosure of HIV status in a clinical trial setting : Antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. In: Clinical Infectious Diseases. 2014 ; Vol. 58, No. 1. pp. 117-120.

@article{5be37f75d61d4aaaa47682409250d1e1,

title = "Nondisclosure of HIV status in a clinical trial setting: Antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection",

abstract = "In The HIV Prevention Trials Network 061 study, 155 human immunodeficiency virus (HIV)-infected men reported no prior HIV diagnosis; 83 of those men had HIV RNA levels of <1000 copies/mL at enrollment. Antiretroviral drug testing revealed that 65 of the 83 (78.3%) men were on antiretroviral treatment. Antiretroviral drug testing can help distinguish between newly diagnosed and previously diagnosed HIV infection.",

author = "Marzinke, {Mark A.} and William Clarke and Lei Wang and Vanessa Cummings and Liu, {Ting Yuan} and Estelle Piwowar-Manning and Autumn Breaud and Sam Griffith and Susan Buchbinder and Steven Shoptaw and {Del Rio}, Carlos and Manya Magnus and Sharon Mannheimer and Fields, {Sheldon D.} and Mayer, {Kenneth H.} and Wheeler, {Darrell P.} and Koblin, {Beryl A.} and Eshleman, {Susan H.} and Fogel, {Jessica M.}",

year = "2014",

month = jan,

day = "1",

doi = "10.1093/cid/cit672",

language = "English (US)",

volume = "58",

pages = "117--120",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "1",

}

Marzinke, MA, Clarke, W, Wang, L, Cummings, V, Liu, TY, Piwowar-Manning, E, Breaud, A, Griffith, S, Buchbinder, S, Shoptaw, S, Del Rio, C, Magnus, M, Mannheimer, S, Fields, SD, Mayer, KH, Wheeler, DP, Koblin, BA, Eshleman, SH & Fogel, JM 2014, 'Nondisclosure of HIV status in a clinical trial setting: Antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection', Clinical Infectious Diseases, vol. 58, no. 1, pp. 117-120. https://doi.org/10.1093/cid/cit672

Nondisclosure of HIV status in a clinical trial setting : Antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. / Marzinke, Mark A.; Clarke, William; Wang, Lei; Cummings, Vanessa; Liu, Ting Yuan; Piwowar-Manning, Estelle; Breaud, Autumn; Griffith, Sam; Buchbinder, Susan; Shoptaw, Steven; Del Rio, Carlos; Magnus, Manya; Mannheimer, Sharon; Fields, Sheldon D.; Mayer, Kenneth H.; Wheeler, Darrell P.; Koblin, Beryl A.; Eshleman, Susan H.; Fogel, Jessica M.

In: Clinical Infectious Diseases, Vol. 58, No. 1, 01.01.2014, p. 117-120.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Nondisclosure of HIV status in a clinical trial setting

T2 - Antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection

AU - Marzinke, Mark A.

AU - Clarke, William

AU - Wang, Lei

AU - Cummings, Vanessa

AU - Liu, Ting Yuan

AU - Piwowar-Manning, Estelle

AU - Breaud, Autumn

AU - Griffith, Sam

AU - Buchbinder, Susan

AU - Shoptaw, Steven

AU - Del Rio, Carlos

AU - Magnus, Manya

AU - Mannheimer, Sharon

AU - Fields, Sheldon D.

AU - Mayer, Kenneth H.

AU - Wheeler, Darrell P.

AU - Koblin, Beryl A.

AU - Eshleman, Susan H.

AU - Fogel, Jessica M.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - In The HIV Prevention Trials Network 061 study, 155 human immunodeficiency virus (HIV)-infected men reported no prior HIV diagnosis; 83 of those men had HIV RNA levels of <1000 copies/mL at enrollment. Antiretroviral drug testing revealed that 65 of the 83 (78.3%) men were on antiretroviral treatment. Antiretroviral drug testing can help distinguish between newly diagnosed and previously diagnosed HIV infection.

AB - In The HIV Prevention Trials Network 061 study, 155 human immunodeficiency virus (HIV)-infected men reported no prior HIV diagnosis; 83 of those men had HIV RNA levels of <1000 copies/mL at enrollment. Antiretroviral drug testing revealed that 65 of the 83 (78.3%) men were on antiretroviral treatment. Antiretroviral drug testing can help distinguish between newly diagnosed and previously diagnosed HIV infection.

UR - http://www.scopus.com/inward/record.url?scp=84891354327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891354327&partnerID=8YFLogxK

U2 - 10.1093/cid/cit672

DO - 10.1093/cid/cit672

M3 - Article

C2 - 24092804

AN - SCOPUS:84891354327

VL - 58

SP - 117

EP - 120

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 1

ER -

Nondisclosure of HIV status in a clinical trial setting: Antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this